PerkinElmer, Inc.
Delayed Nyse - 12/15 10:05:29 pm

PerkinElmer : to buy Germany's Euroimmun for about $1.3 billion

Envoyer par e-mail
06/19/2017 | 09:52 am
(Reuters) - Scientific instruments maker PerkinElmer Inc said on Monday it would buy Germany's Euroimmun Medical Laboratory Diagnostics AG for about $1.3 billion (1.02 billion pounds) in cash to expand its reach into autoimmune and allergy diagnostic markets.

The deal also offers new infectious disease capabilities to its customers in China, PerkinElmer said.

The acquisition is expected to add about $0.28 to $0.30 per share to PerkinElmer's 2018 adjusted earnings, it said, and reaffirmed its 2017 revenue and earnings per share forecast.

Lubeck, Germany-based Euroimmun, which has about 2,400 employees, is expected to generate about $310 million in revenue this year, PerkinElmer said in a statement.

The deal is expected to close in the fourth quarter of 2017, PerkinElmer said.

(Reporting by Subrat Patnaik in Bengaluru; Editing by Gopakumar Warrier)

Reuters 2017
Envoyer par e-mail